Edmund Tai, MD
Anatomic Pathology & Clinical Pathology · Mountain View, CANPI 1487669933
Payments from drug & device makers
Across 243 payments — averaging $729.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$128K
- Merck$17K
- AstraZeneca$15K
- Novartis$7K
- Genentech USA, Inc.$3K
- Boehringer Ingelheim$3K
- plus $5K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 119 | $127,765 |
| Merck | 4 | $17,427 |
| AstraZeneca | 41 | $14,595 |
| Novartis | 6 | $6,515 |
| Genentech USA, Inc. | 6 | $3,039 |
| Boehringer Ingelheim | 1 | $2,670 |
| Pfizer | 32 | $1,905 |
| GSK | 3 | $1,883 |
| Bayer | 1 | $900 |
| Daiichi Sankyo Inc. | 5 | $124 |
| Johnson & Johnson(2 entities) | 4 | $118 |
| Secura Bio, Inc. | 3 | $82 |
| AbbVie | 2 | $42 |
| Gilead | 2 | $37 |
| Genentech, Inc. | 2 | $35 |
| Stemline Therapeutics Inc. | 1 | $29 |
| Clovis Oncology, Inc. | 2 | $27 |
| Coherus Oncology, Inc. | 1 | $26 |
| Array Biopharma Inc | 1 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $12 |
| Seagen Inc. | 1 | $12 |
How this compares
$177,368 in reported general payments places this provider in the 95th percentile of 814 anatomic pathology & clinical pathology providers in California.
See all anatomic pathology & clinical pathology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Mountain View
- Serge AlexanianLos Angeles$3.2M
- Cynthia BehlingSan Diego$1.1M
- Michael LewisLos Angeles$1.1M
- Alexander BorowskySan Francisco$778K
- Benjamin PinskyStanford$673K
- Brian ConeLos Angeles$519K
- John BlausteinSanta Barbara$464K
- Henry TsaiHuntington Beach$414K
- Stewart ComerSanta Barbara$313K
- Miriam Blochla Jolla$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.